Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
17.68
+1.56 (9.68%)
Nov 22, 2024, 4:00 PM EST - Market closed
Pulse Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -46.13 | -42.21 | -58.51 | -63.66 | -49.85 | -46.97 | Upgrade
|
Depreciation & Amortization | 1.2 | 1.21 | 1.36 | 1.15 | 1.1 | 1.16 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 0.19 | - | 0.12 | - | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | 0.01 | -0 | -0.52 | Upgrade
|
Stock-Based Compensation | 10.14 | 7.18 | 5.19 | 14.6 | 10.08 | 11.29 | Upgrade
|
Other Operating Activities | - | - | 8.48 | - | - | - | Upgrade
|
Change in Accounts Receivable | - | - | 0.06 | -0.06 | - | - | Upgrade
|
Change in Inventory | - | - | -2.65 | -5.82 | - | - | Upgrade
|
Change in Accounts Payable | 0.24 | 0.26 | -1.3 | 1.16 | -0.27 | 0.65 | Upgrade
|
Change in Unearned Revenue | - | - | -0.02 | 0.02 | - | - | Upgrade
|
Change in Other Net Operating Assets | 0.56 | 0.51 | 0.2 | -1.49 | 3.47 | 0.21 | Upgrade
|
Operating Cash Flow | -33.98 | -33.04 | -47.01 | -54.1 | -35.37 | -34.19 | Upgrade
|
Capital Expenditures | -0.12 | -0.12 | -0.4 | -0.44 | -0.44 | -0.61 | Upgrade
|
Investment in Securities | - | - | - | 8 | 10.49 | -9.49 | Upgrade
|
Investing Cash Flow | -0.12 | -0.12 | -0.4 | 7.56 | 10.04 | -10.1 | Upgrade
|
Short-Term Debt Issued | - | - | - | 1.94 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | 65 | - | - | - | Upgrade
|
Total Debt Issued | - | - | 65 | 1.94 | - | - | Upgrade
|
Short-Term Debt Repaid | - | - | -0.44 | -1.53 | - | - | Upgrade
|
Total Debt Repaid | - | - | -0.44 | -1.53 | - | - | Upgrade
|
Net Debt Issued (Repaid) | - | - | 64.56 | 0.41 | - | - | Upgrade
|
Issuance of Common Stock | 62.97 | 16.39 | 15.38 | 62.51 | 30.89 | 0.7 | Upgrade
|
Repurchase of Common Stock | - | - | - | -0.23 | - | -0.61 | Upgrade
|
Other Financing Activities | -0.22 | -0.01 | - | - | - | - | Upgrade
|
Financing Cash Flow | 62.74 | 16.39 | 79.94 | 62.69 | 30.89 | 0.08 | Upgrade
|
Net Cash Flow | 28.65 | -16.77 | 32.53 | 16.15 | 5.56 | -44.2 | Upgrade
|
Free Cash Flow | -34.1 | -33.16 | -47.41 | -54.53 | -35.81 | -34.79 | Upgrade
|
Free Cash Flow Margin | - | - | -6773.43% | -3845.84% | - | - | Upgrade
|
Free Cash Flow Per Share | -0.61 | -0.69 | -1.40 | -1.95 | -1.54 | -1.68 | Upgrade
|
Cash Interest Paid | 1.7 | 1.7 | - | - | - | - | Upgrade
|
Levered Free Cash Flow | -18.81 | -18.13 | -26.84 | -30.4 | -18.77 | -17.01 | Upgrade
|
Unlevered Free Cash Flow | -18.13 | -17.44 | -26.27 | -29.96 | -18.77 | -17.01 | Upgrade
|
Change in Net Working Capital | -0.99 | -1.53 | -3.87 | 5.89 | -1.73 | -1.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.